Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
03/30/1993 | CA1315222C Polynucleotide probes and a method for their preparation |
03/24/1993 | EP0532878A2 Process for producing acyclic nucleosides |
03/24/1993 | EP0510085A4 Dna-dependent rna polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays |
03/24/1993 | CN1070191A 1,3-oxathiolane nucleoside analogues |
03/23/1993 | US5196402 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant |
03/23/1993 | CA1314875C Therapeutic nucleosides |
03/18/1993 | WO1993005163A1 Method for the selection of genetically transformed cells and compounds for use in the method |
03/18/1993 | WO1993005059A1 Imidazolidyl macrolides |
03/18/1993 | WO1993005058A1 O-heteroaryl, o-alkylheteroaryl, o-alkenylheteroaryl and o-alkynylheteroarylmacrolides |
03/18/1993 | WO1993005042A1 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions |
03/18/1993 | WO1993004680A1 Macrocyclic immunomodulators |
03/17/1993 | EP0532089A1 N-heteroaryl, N-alkylheteroaryl, N-alkenylheteroaryl & N-alkynylheteroarylmacrolides |
03/17/1993 | EP0532088A1 O-Heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroaryl macrolides |
03/17/1993 | EP0531452A1 Synthesis of glycerol di- and triphosphate derivatives |
03/17/1993 | CN1020114C Preparation for macrolide compounds |
03/17/1993 | CN1020107C Process for antivirotic compound |
03/17/1993 | CN1020106C Process for pyrimidine derivatives |
03/16/1993 | US5194654 Viricides for retroviral infections such as aids |
03/16/1993 | US5194599 Hydrogen phosphonodithioate compositions |
03/16/1993 | CA1314503C Detectable molecules, method of preparation and use |
03/10/1993 | EP0530901A1 13-beta-O-methoxymethyl-22,23-dihydro avermectin B1A/B1B aglycone |
03/10/1993 | EP0530888A1 Fluoromacrolides having immunosuppressive activity |
03/10/1993 | EP0530614A1 Novel antisense oligonucleotider with continuous phosphoramidate internucleotide linkage |
03/10/1993 | EP0530407A1 Substituted, nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them |
03/10/1993 | CA2077638A1 N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n- alkynylheteroarylmacrolides having immunosuppressive activity |
03/10/1993 | CA2077331A1 O-heteroaryl, o-alkylheteroaryl, o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosuppressive activity |
03/09/1993 | US5192777 Macrolide compounds |
03/09/1993 | US5192764 Pyrazinone n-oxide nucleosides and analogs thereof |
03/09/1993 | US5192749 4'-substituted nucleosides |
03/09/1993 | US5192671 Fermentation with Saccharopolyspora |
03/09/1993 | CA1314245C Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators |
03/06/1993 | WO1993004679A1 Macrocyclic immunomodulators |
03/06/1993 | CA2103453A1 Macrocyclic immunomodulators |
03/05/1993 | CA2077466A1 Substituted nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them |
03/05/1993 | CA2077131A1 13beta-o-methoxymethyl-22,23-dihydro avermectin b1a-b1b aglycone as a superior antiparasitic agent |
03/05/1993 | CA2050664A1 Antitumor aldophosphamide analogs |
03/04/1993 | WO1993003736A1 Cross-linking oligonucleotides for enzyme-mediated triple strand formation |
03/04/1993 | WO1993003734A1 Method for lowering blood lipid levels |
03/04/1993 | WO1993003733A1 Syntheses, pharmaceutical composition and method of application of (2'-5') oligoadenylate analogues |
03/04/1993 | CA2115675A1 Method for lowering blood lipid levels |
03/04/1993 | CA2077314A1 Antisense oligonucleotides with phosphoramidate internucleotide linkage throughout |
03/03/1993 | EP0530129A1 Method for the selection of genetically transformed cells and compounds for use in the method |
03/03/1993 | EP0528870A1 Protein-nucleic acid probes and immunoassays using same |
03/02/1993 | US5190950 Antagonists of immunosuppressive macrolides |
03/02/1993 | US5190948 Use of uridine in the pharmacological treatment of the peripheral complications of diabetes |
03/02/1993 | US5190926 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents |
02/24/1993 | EP0528030A1 Antitumor be-13793c derivative |
02/24/1993 | EP0527917A1 Use of adenosine and adenosine derivatives for anesthesia |
02/23/1993 | US5189042 Fluoromacrolides having immunosuppressive activity |
02/23/1993 | US5189027 Hypotensive agent, vasoconstriction |
02/23/1993 | US5188944 Process for the glycosylation of avermectin agylcones |
02/23/1993 | CA2076419A1 Fluoromacrolides having immunosuppressive activity |
02/23/1993 | CA1313866C 2'-deoxy-5-fluorouridine derivatives |
02/18/1993 | WO1993003051A1 A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide |
02/18/1993 | WO1993003048A1 Process for purifying pentostatin |
02/18/1993 | WO1993003038A1 Novel cholesterol lowering compound |
02/18/1993 | WO1993003027A1 1,3-oxathiolane nucleoside analogues |
02/18/1993 | WO1993002703A1 Prodrugs activated by targeted catalytic proteins |
02/18/1993 | WO1993002683A1 Composition for curing proliferative skin diseases |
02/18/1993 | CA2114934A1 Prodrugs activated by targeted catalytic proteins |
02/18/1993 | CA2113902A1 Novel cholesterol lowering compound |
02/17/1993 | EP0527646A1 New compounds named the adenophostins, their preparation and their therapeutic use |
02/16/1993 | US5187266 Antitumor aldophosphamide glycoside and dideoxyuridine derivatives |
02/16/1993 | US5187163 Anti-viral compounds, dosage forms and methods |
02/16/1993 | CA1313661C 2'-deoxy-5-fluorouridine derivatives |
02/10/1993 | EP0526935A1 New microorganism for producing C-31 desmethyl FR-900520 cyclic hemiketal |
02/10/1993 | EP0526934A1 New C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent |
02/10/1993 | EP0526866A1 The use of adenosine compounds for the preparation in the treatment of ischaemia |
02/09/1993 | US5185456 Macrolide compounds |
02/09/1993 | US5185437 Therapeutic nucleosides |
02/09/1993 | CA1313498C 3'-azido-2', 3'-dideoxyuridine anti-retroviral composition |
02/08/1993 | CA2075543A1 Use of adenosine compounds in the treatment of ischaemia |
02/08/1993 | CA2067540A1 Rapamycin analog as immunosuppressants and antifungals |
02/04/1993 | WO1993002091A1 Monosaccharide analog-based glycosidase inhibitors |
02/04/1993 | WO1993002082A1 Cyclic ketal derivatives |
02/04/1993 | WO1992020336A3 Novel cholesterol lowering compounds |
02/04/1993 | DE4215738A1 Novel microorganism Streptomyces albus R2374 - is e.g 5-0-sulphamoyl-2-chloro adenosine which can be used as a herbicide |
02/03/1993 | EP0526253A1 1,3-Oxathiolane nucleoside analogues |
02/03/1993 | EP0525479A1 Spicamycin derivatives and the use thereof |
02/03/1993 | EP0525106A1 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
02/03/1993 | EP0524997A1 2'-o-alkyl nucleotides and polymers containing them. |
02/03/1993 | CN1068574A Atp analogues |
02/02/1993 | US5183882 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
02/02/1993 | US5183749 One step fermentation for carrying out hydroxylation or epoxidation or both reactions |
02/02/1993 | CA2074861A1 Microorganism for producing c-31 desmethyl fr-900520 cyclic hemiketal immunosuppressant agent |
02/02/1993 | CA2074856A1 C-31 desmethyl fr-900520 cyclic hemiketal immunosuppressant agent |
01/27/1993 | EP0524687A1 A process for the glycosylation of avermectin compounds at the 14a-position |
01/27/1993 | EP0524686A1 A process for the 14a-hydroxylation of avermectin compounds |
01/27/1993 | EP0524677A1 Cyclic ketal derivatives |
01/26/1993 | US5182207 Strains of streptomyces thermoarchaensis |
01/26/1993 | CA1313155C Antibiotic compounds and their preparation |
01/24/1993 | CA2074328A1 Process for the 14a-hydroxylation of avermectin compounds |
01/24/1993 | CA2074327A1 Process for the glycosylation of avermectin compounds at the 14a-position |
01/21/1993 | WO1993001204A1 Method and compounds for rna synthesis |
01/21/1993 | WO1993001202A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
01/21/1993 | WO1993000910A1 Antiviral liponucleosides: treatment of hepatitis b |
01/21/1993 | DE4223438A1 Cyclische oligonucleotidphosphorthioate Cyclic oligonucleotidphosphorthioate |
01/21/1993 | CA2112803A1 Antiviral liponucleosides: treatment of hepatitis b |
01/20/1993 | EP0523110A1 Nucleoside derivatives |
01/20/1993 | CN1068111A Derivatives of (hetero) aromatic ethers and thioethers process for preparing same and pharmaceutical composition containing them |